My father once stated, “of all the forms of inequality, injustice in health care is the most shocking and inhumane.” These words remain relevant as America faces a significant public health challenge. Many families across the nation are dealing with obesity, a chronic disease that disproportionately impacts low-income communities and people of color. Despite this, numerous affected individuals lack access to effective, transformative treatments recognized by medical experts.
This is not solely a health care issue; it is a matter of fairness and equal opportunity. Recent actions by states like California, which limit coverage for GLP-1 treatments for obesity, highlight a growing national problem. Effective treatments exist but often are only available to those who can afford them.
The principle that living conditions or income should not decide one’s chance to live healthily means little if effective obesity treatments are mainly available to people with private insurance or the financial means to pay. Consequently, our health care system heavily relies on income to provide treatment access.
Obesity is linked to chronic illnesses like heart disease, stroke, diabetes, kidney disease, and hypertension. These conditions shorten lives, burden families, and elevate health care costs. Recent treatment advances have provided hope to many Americans. These treatments enable individuals to enhance their health and manage obesity as a chronic disease. For numerous patients, the issue is not about appearance but about obtaining medically necessary care.
Parents gain energy to engage with their children. Workers improve their health and can better support their families. Patients previously stuck in cycles of ineffective treatments now witness progress. Yet, this hope is futile if access remains restricted to those who can afford it.
Without Medicaid coverage for obesity treatment, low-income patients endure worsening health conditions. Delaying care elevates costs to emergency rooms, hospital stays, and preventable suffering, rather than saving money. Policymakers must acknowledge obesity treatment as essential health care, not a luxury.
This is crucial for communities facing higher obesity and chronic disease rates. Reducing health disparities requires providing access to promising treatment tools. Sadly, stigma still influences our discourse on obesity, with affected individuals often facing judgment. We should treat obesity with seriousness, similar to other chronic diseases, and provide the same respect and treatment access.
No one deserves to be told to simply try harder. Health care should be universally accessible, regardless of ZIP code, insurance plan, or income. Medicaid is designed to ensure care is not wealth-dependent. Excluding obesity treatment contradicts this mission. The question for policymakers is straightforward: Who deserves access to modern medicine?
To build a healthier nation, we must not abandon communities already struggling with significant health inequities. Expanding Medicaid access to obesity treatment will not solve all health care challenges, but it is a crucial step towards making medical advancements accessible to all Americans, not just the financially able.
The true measure of our society lies not in whether the fortunate can access lifesaving care, but in our willingness to provide care to those in greatest need.
Martin Luther King III is a global humanitarian, activist, and the eldest son of the Rev. Martin Luther King Jr. The views expressed in this article are the writer’s own.
Leave a Reply